businesswire.comRevvity Announces Financial Results for the Fourth Quarter and Full Year of 20246 months ago
businesswire.comRevvity Announces Financial Results for the Fourth Quarter and Full Year of 20246 months ago
businesswire.comRevvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing7 months ago
businesswire.comRevvity Announces FDA Clearance for First Automated Free Testosterone Test7 months ago
CashuRevvity's Profit Forecast Revision Signals Strategic Challenges Ahead in Life Sciences3 days ago
CashuRevvity Analysts Show Mixed Confidence Amidst Industry Challenges and Growth Potentialabout 1 month ago